Skip to main navigation
Skip to search
Skip to main content
Bond University Research Portal Home
Help & FAQ
Home
Profiles
Research units
Research Outputs
Student theses
Datasets
Activities
Press/Media
Projects
Search by expertise, name or affiliation
FDA advisers warn of more deaths if drug is relaunched.
Ray Moynihan
*
*
Corresponding author for this work
Institute for Evidence-Based Healthcare
Research output
:
Contribution to journal
›
Article
›
Professional
5
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'FDA advisers warn of more deaths if drug is relaunched.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
alosetron
100%
United States Food and Drug Administration
28%
Pharmaceutical Preparations
23%
Wounds and Injuries
13%